aim
studi
elucid
isatidi
radix
tonic
aqueou
mixtur
hundr
composit
interrupt
infect
influenza
virus
host
cell
efficaci
tonic
evalu
express
cell
prolifer
rate
plaqu
reduct
rate
madindarbi
canin
kidney
mdck
cell
strain
influenza
b
virus
boil
water
extract
isatidi
radix
rie
show
antivir
activ
influenza
viru
b
concentr
inhibit
influenza
viru
replic
ic
mdck
cell
mgml
therapeut
index
cell
incub
rie
prior
viru
adsorpt
number
viabl
cell
least
doubl
compar
number
viru
control
rie
incub
viru
adsorpt
rie
incub
viru
prior
adsorpt
influenza
viru
b
moreov
much
less
viru
particl
spot
scan
electron
microscop
sem
rie
pretreat
cell
cell
without
rie
treatment
result
indic
antivir
activ
rie
mainli
attribut
host
cell
protect
effect
action
viru
postvirusadsorpt
interrupt
cell
viru
like
action
target
rie
previou
studi
chen
rie
demonstr
prevent
influenza
viru
induc
hemaegglutin
remark
chang
surfac
charg
erythrocyt
measur
capillari
electrophoresi
erythrocyt
lu
impli
antihemaegglutin
activ
rie
might
reli
action
upon
erythrocyt
rather
viru
paper
sought
determin
antivir
activ
rie
use
madindarbi
canin
kidney
mdck
cell
strain
influenza
viru
b
attempt
made
identifi
either
cell
viru
target
rie
action
comparison
antivir
efficaci
rie
interfer
introduc
viru
adsorpt
mdck
cell
fresh
root
isati
indigotica
fort
harvest
sundri
fuyang
citi
anhui
provinc
pr
china
root
dri
day
night
week
yield
sun
dri
kg
sundri
root
kg
fresh
root
prepar
aqueou
extract
isatidi
radix
rie
follow
instruct
china
pharmacopeia
chines
pharmacopoeia
commiss
g
sundri
root
extract
twice
l
boil
water
h
h
respect
solut
filter
vacuum
concentr
rel
densiti
reach
stock
precipit
ethanol
precipit
remov
suspens
vacuum
concentr
produc
rie
brown
powder
continu
mdck
cell
china
center
type
cultur
collect
maintain
dmem
invitrogen
corpor
calf
serum
gibco
penicillin
g
mgl
streptomycin
mgl
sodium
bicarbon
gl
influenza
strain
e
purchas
nation
influenza
center
china
influenza
viru
mouseadapt
strain
gener
provid
fujian
centr
diseas
control
fuzhou
fujian
prchina
virus
propag
allanto
caviti
chick
embryo
h
isol
viru
stock
store
aliquot
phosphat
buffer
salin
cytotox
effect
decoct
mgml
determin
dye
uptak
assay
crystal
violet
wv
use
mdck
cell
schmidtk
et
al
six
duplic
use
concentr
cell
viabil
present
cell
surviv
rate
calcul
equat
follow
establish
protocol
levi
mdck
cell
monolay
cellswel
plate
wash
pb
infect
pfu
plaqu
form
unit
influenza
viru
min
presenc
absenc
rie
infect
cell
incub
mainten
medium
contain
rie
mgml
antivir
activ
determin
use
mtt
assay
van
de
loosdrecht
et
al
plaqu
reduct
assay
gaush
smith
burleson
cell
control
withwithout
extract
viru
control
includ
antivir
activ
calcul
percentag
protect
virusinduc
cell
prolifer
inhibit
cell
destruct
relat
infect
cell
without
rie
mockinfect
control
equat
concentr
inhibit
viru
ic
calcul
reedmuench
method
reed
muench
determin
antivir
activ
differ
singl
concentr
rie
mgml
introduc
influenza
viru
three
differ
mode
cell
protect
mode
cell
pretreat
rie
min
viru
adsorpt
cell
repair
mode
viru
adsorpt
infect
cell
incub
rie
min
wash
twice
pb
viru
diminish
mode
viru
preincub
rie
min
introduc
cell
antivir
activ
differ
mode
determin
mtt
assay
present
cell
viabil
calcul
equat
scan
electron
microscop
use
directli
observ
morpholog
cytopathogen
induc
pfu
influenza
mdck
cell
grown
confluenc
polyethyleneimineco
cover
slip
mm
diamet
plastic
tissu
cultur
plate
mm
well
diamet
rie
mgml
administr
cell
mode
describ
addit
investig
rie
effect
viru
adsorpt
cell
withwithout
rie
pretreat
incub
virus
h
allow
occurr
viru
attach
cell
membran
cell
prepar
sem
observ
establish
protocol
watanab
et
al
wash
pb
buffer
time
cell
fix
paraformaldehyd
cacodyl
buffer
ph
h
room
temperatur
postfix
oso
buffer
min
follow
thoroughli
wash
dehydr
ethanol
treat
isoamyl
acet
dri
critic
point
cell
mount
stub
coat
gold
observ
scan
electron
microscop
jeol
cell
surviv
rate
decreas
significantli
concentr
rie
risen
mgml
wherea
signific
differ
observ
concentr
lower
mgml
lowest
cell
surviv
rate
assay
rie
concentr
mgml
indic
cytotox
concentr
cc
rie
mdck
cell
estim
mgml
shown
tabl
moreov
test
incub
mgml
rie
cell
influenza
viru
togeth
rais
cell
surviv
rate
plaqu
inhibit
rate
surviv
rate
higher
counterpart
cytotox
test
presenc
high
concentr
rie
impact
rie
treatment
viabil
normal
cell
subtract
evalu
rie
influenc
viral
infect
result
indic
rie
effici
inhibit
viral
infect
even
cytotox
concentr
moreov
ic
rie
rang
mgml
seem
high
effici
antivir
agent
howev
two
factor
taken
account
firstli
ic
evalu
rie
introduc
cell
viru
togeth
instead
prior
viru
incub
might
provid
undervalu
ic
secondli
mixtur
rie
contain
hundr
composit
small
proport
would
respons
efficaci
exampl
one
fifth
total
protein
isatidi
radix
aqueou
solubl
nagai
et
al
report
antiinfluenza
viru
activ
glycoprotein
root
isati
tinctoria
l
nagai
et
al
therefor
aqueou
solubl
protein
may
possibl
contribut
antivir
effect
isatidi
radix
purif
effect
compon
rie
progress
envelop
virus
infecti
cycl
influenza
viru
primarili
involv
four
step
bind
receptor
membran
membran
fusion
entri
replic
assembl
bud
whittak
digard
togeth
provid
sever
opportun
antivir
agent
inhibit
viral
infecti
cycl
act
either
host
cell
tabl
antivir
activ
extract
isatidi
radix
strain
influenza
viru
b
use
mtt
assay
plaqu
reduct
assay
therapeut
index
ti
calcul
equat
ti
cc
ic
cc
mgml
real
cc
estim
higher
mgml
ti
valu
higher
result
calcul
virus
exampl
antibodi
inhibit
attach
virus
cell
read
dimmock
peptidyl
chloroalkyl
keton
inhibitor
prevent
fusion
event
inhibit
cleavag
precursor
ha
tashiro
rott
approv
drug
amantadin
rimantadin
stop
viral
particl
releas
cytoplasm
inhibit
viral
particl
uncoat
pinto
lamb
neuraminidas
inhibitor
ie
tamiflu
prevent
bud
progeni
viru
cell
membran
moscona
prior
antivir
mechan
rie
compon
illumin
action
target
rie
firstli
narrow
either
cell
virus
antihemaegglutin
activ
rie
attribut
action
upon
erythrocyt
rather
viru
chen
et
al
likewis
anoth
r
n
l
c
h
n
e
e
h
e
r
b
l
n
c
r
c
e
charantia
fructu
extract
shown
cytoprotect
effect
pancreat
islet
cell
ke
et
al
therefor
rie
hypothesis
conduct
cytoprotect
effect
viru
host
cell
ie
mdck
cell
studi
import
note
efficaci
rie
correspond
stage
viru
infect
rie
interf
contrast
viru
control
cell
protect
mode
achiev
signific
improv
p
cell
surviv
rate
among
three
mode
shown
tabl
wherea
neither
cell
repair
mode
viru
diminish
mode
correspond
cell
surviv
rate
viru
titr
suspens
measur
hemaegglutin
assay
decreas
cell
protect
mode
cell
consist
cell
viabil
test
cytopathogen
effect
cpe
mdck
cell
observ
sem
cell
protect
mode
cell
incub
rie
prior
viru
infect
much
fewer
viru
particl
appear
surfac
rie
pretreat
cell
figur
cell
without
rie
treatment
figur
ensur
propos
inhibitori
effect
concentr
rie
use
sem
studi
mgml
middl
valu
effect
concentr
influenza
viru
two
assumpt
drawn
result
firstli
rie
fail
prevent
viral
infect
direct
action
virus
neutralis
rie
assum
act
mdck
cell
rather
influenza
virus
secondli
rie
bind
cell
plasma
membran
enter
cell
plasma
affect
earli
event
viral
extract
isatidi
radix
rie
mgml
use
group
prolifer
rate
normal
madindarbi
canin
kidney
cell
control
defin
rie
show
protect
effect
viru
cell
protect
mode
effect
cell
repair
mode
viru
diminish
mode
p
other
p
protect
mode
rie
pretreat
cell
incub
virus
magnifi
b
control
without
rie
pretreat
cell
incub
virus
magnifi
cell
fix
karnovski
fix
postfix
oso
min
dehydr
ethanol
treat
isoamyl
acet
dri
critic
point
cell
mount
stub
coat
gold
observ
scan
electron
microscop
jeol
arrow
viru
particl
bound
microvilli
part
plasma
membran
infect
ie
bind
fusion
membran
thereaft
uncoat
viru
particl
cytoplasm
assumpt
base
follow
observ
free
rie
thoroughli
wash
incub
cell
three
group
rie
bound
cell
plasma
membran
internalis
cell
plasma
would
contribut
rise
cell
surviv
rate
furthermor
stronger
effect
protect
mode
repair
mode
crucial
rie
particip
cellviru
interact
earli
stage
particular
prior
presenc
virus
henc
inhibitori
effect
rie
viral
infect
may
confin
adsorpt
fusion
stage
infect
assumpt
support
sem
studi
assay
viru
particl
seen
bind
rie
pretreat
cell
present
studi
indic
decoct
isatidi
radix
inhibit
attach
influenza
viru
mdck
cell
bind
subsequ
modifi
cell
plasma
membran
first
time
target
antivir
tradit
chines
medicin
locat
host
cell
potenti
new
famili
antivir
agent
may
develop
rie
use
uniqu
antivir
approach
prevent
viru
attach
host
cell
plasma
membran
furthermor
target
univers
substanc
cell
plasma
membran
approach
may
function
upon
wide
rang
envelop
virus
regardless
famili
type
strain
year
epidem
beauti
due
high
conserv
membran
lipid
approach
expect
low
risk
develop
viru
resist
studi
request
purifi
effect
compon
rie
identifi
bind
site
cell
membran
